Hyperbaric oxygen therapy as an adjuvant therapy for comprehensive treatment of Fournier's gangrene - Abstract

Objectives: To compare simple conventional treatment with the addition of hyperbaric oxygen therapy (HBOT) to conventional therapies in the treatment of Fournier's gangrene (FG).

Methods: A retrospective study of clinical data was performed by reviewing 28 cases of FG from January 2004 to December 2013 at Xiangya Hospital, Central South University. Among them, 12 patients were treated with the conventional therapy (non-HBOT group) and the other 16 cases were combined with hyperbaric oxygen therapy besides conventional therapy (HBOT group). All patients were followed up for 2 months to assess the therapeutic effect. The analyzed data included age, Fournier gangrene severity index (FGSI) score, number of surgical debridement, indwelling drainage tube time, length of stay (LOS), effective time, and curative time.

Results: The mortality rate was lower in the HBOT group at 12.5% (2/16) compared to the non-HBOT group, which was 33.3% (4/12). The difference in the number of surgical debridement, indwelling drainage tube time, and curative time between were significantly lower in the HBOT group compared to the non-HBOT group.

Conclusions: Our preliminary research suggests that the effect of combining hyperbaric oxygen therapy with conventional therapy offers considerable advantage in the management of Fournier's gangrene. Multicenter studies with a larger sample size are required to confirm these observations.

Written by:
Li C, Zhou X, Liu LF, Qi F, Chen JB, Zu XB.   Are you the author?
Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Reference: Urol Int. 2015 Feb 7. Epub ahead of print.
doi: 10.1159/000366137


PubMed Abstract
PMID: 25677386

UroToday.com Infections Section

email news signup